Topic: AS06-Prognosis/AS06b-Predictive factors of response to treatment: AUGMENTED ACTIVITY OF THE ALVOCIDIB AND 5-AZACYTIDINE COMBINATION IN MYELODYSPLASTIC NEOPLASMS IS ASSOCIATED WITH THE PRESENCE OF ASXL1 MUTATIONS. (May 2023) - Ryabov, V.; Xu, Q.; Schmitt, N.; Streuer, A.; Ge, G.; Bolanos, L.; Wunderlich, M.; Jann, J.-C.; Wein, A.; Altrock, E.; Mukherjee, S.; Ali, A.M.; et al.